Within the research centers, technology platforms offer companies access to state-of-the-art equipment and team expertise.
BiotechMarine develops assets based on algae and seaside plants. As it did not have in-house the analytical capabilities and expertise to compare algal biomasses from biotechnologies from a metabolic point of view, it turned to the Métabomer platform which is part of the common services of the Roscoff Marine Station.
Cédric Leroux (Thenical Officer of the platform) and Julien Fouilland (Phytochemistry Projet Manager at BiotechMarine) testify about their collaboration in this video.